Bliss GVS Pharma Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 221.20 | 174.91 | 203.82 |
| Operating Expense | 167.39 | 140.34 | 159.96 |
| Net Profit | 32.42 | 18.61 | 24.79 |
| Net Profit Margin | 14.66% | 10.64% | 12.16% |
| Earning Per Share | 3.06 | 1.76 | 2.35 |
| EBIDTA | 53.13 | 35.41 | 46.60 |
| Effective Tax Rate | 20.55% | 21.75% | 26.01% |
Particulars
Mar 2026
Revenue221.20
Operating Expense167.39
Net Profit32.42
Net Profit Margin14.66
Earning Per Share3.06
EBIDTA53.13
Effective Tax Rate20.55
